Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Allarity disclosed on July 22, 2024, that it received a Wells Notice from the SEC concerning “the Company’s disclosures regarding meetings with the United States Food and Drug Administration (the “FDA”) regarding the Company’s NDA for Dovitinib or Dovitinib-DRP, which was submitted to the FDA in 2021.” On this news, the price of the Company’s stock dropped.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |
| GSK | GSK plc | April 07, 2025 | Join |
| NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
| MRK | Merck & Co., Inc. | April 14, 2025 | Join |